METABOLOMIC AND LIPIDOMIC ANALYSIS OF PATIENTS WITH PRESUMED METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) TREATED WITH THE SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR MIRICORILANT

被引：0
|
作者：
Kowdley, Kris [1 ]
Noureddin, Mazen [2 ]
Parks, Elizabeth [3 ]
Botbyl, Jeffrey [4 ]
Monibas, Rafael Mayoral [4 ]
Wadekar, Subhagya [4 ]
Espinueva, Aprille [4 ]
Juneja, Kavita [4 ]
Schwab, Andrew [5 ]
Alkhouri, Naim [6 ]
机构：
[1] Liver Inst Northwest, Seattle, WA USA
[2] Houston Methodist Hosp, Houston, TX USA
[3] Univ Missouri, Columbia, MO USA
[4] Corcept Therapeut Inc, Menlo Pk, CO USA
[5] Metabolon, Durham, NC USA
[6] Arizona Liver Hlth, Phoenix, AZ USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1637
引用
收藏
页数：3
相关论文
共 50 条
  • [21] UNVEILING THE HIDDEN CONNECTION: EXPLORING THE INTERPLAY BETWEEN PERICARDITIS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
    Ramirez, Lisnaldy
    Garzon-Siatoya, Wendy
    Aloum, Khalid
    Forlemu, Arnold Nongmoh
    Bandaru, Praneeth
    Ciobanu, Camelia
    Wakil, Ali
    Forlemu, Raissa Nana Sede Mbakop
    Krishna, Vura Naga Venkata Rama
    Sharma, Neha
    HEPATOLOGY, 2024, 80 : S472 - S472
  • [22] ECONOMIC COST OF INACTION FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN GERMANY, JAPAN, AND THE UNITED STATES
    Younossi, Zobair
    Tacke, Frank
    Schattenberg, Joern
    Roden, Michael
    Lazarus, Jeffrey
    Allen, Alina
    Cusi, Kenneth
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Kawaguchi, Takumi
    Wong, Vincent
    Mark, Henry
    Brachowicz, Nicolai
    Henry, Linda
    Nader, Fatema
    Paik, James
    HEPATOLOGY, 2024, 80 : S816 - S817
  • [23] EXTRACELLULAR VESICLES AS A THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND HEPATOCELLULAR CARCINOMA (HCC)
    Goonetilleke, M.
    Correia, J.
    Chen, Y.
    McDonald, H.
    Chan, S. T.
    Simpson, I.
    Inocencio, I. M.
    Sievert, W.
    Lim, R.
    CYTOTHERAPY, 2024, 26 (06) : S75 - S76
  • [24] Cost of inaction for metabolic dysfunction-associated steatohepatitis (MASH): the projected economic burden in the United States
    Younossi, Zobair
    Lazarus, Jeffrey V.
    Allen, Alina M.
    Cusi, Kenneth
    Tacke, Frank
    Roden, Michael
    Schattenberg, Jorn M.
    Mark, Henry E.
    Henry, Linda
    Nader, Fatema
    Paik, James M.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S470 - S471
  • [25] Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects
    Hunt, Hazel J.
    Donaldson, Kirsteen
    Strem, Mark
    Tudor, Iulia Cristina
    Sweet-Smith, Suzanne
    Sidhu, Sharan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (06) : 632 - 637
  • [26] Metabolic Bariatric Surgery for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Scoping Review of Biomarker and Histology Changes
    Shah, A.
    Mohammadi, A.
    Haq, A.
    Walji, D.
    Zevin, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 297 - 299
  • [27] ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
    Convertini, Paolo
    Santarsiero, Anna
    Todisco, Simona
    Gilio, Michele
    Palazzo, Donatella
    Pappalardo, Ilaria
    Iacobazzi, Dominga
    Frontuto, Maria
    Infantino, Vittoria
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [28] Development and validation of CLDQ-MASH: a disease specific health related quality of life instrument for patients with metabolic dysfunction-associated steatohepatitis (MASH)
    Younossi, Zobair
    Stepanova, Maria
    Younossi, Issah
    Racila, Andrei
    JOURNAL OF HEPATOLOGY, 2024, 80 : S101 - S102
  • [29] ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis
    Paolo Convertini
    Anna Santarsiero
    Simona Todisco
    Michele Gilio
    Donatella Palazzo
    Ilaria Pappalardo
    Dominga Iacobazzi
    Maria Frontuto
    Vittoria Infantino
    Journal of Translational Medicine, 21
  • [30] Associations Between Laboratory Results and Mortality in Patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Diabetes and Antihypertensive Drug Status
    Guillot, Jordan
    Williams, Christopher
    Slatter, Shadera
    Lo Re, Vin
    Rentsch, Christopher T.
    Ge, Jin
    Rudrapatna, Vivek
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 558 - 558
12345